-
Wed04Jun2025Sat07Jun2025
-
Thu12Jun2025Fri13Jun2025
-
Thu26Jun2025Sat28Jun2025
-
Thu02Oct2025Sat04Oct2025
-
Thu30Oct2025Sat01Nov2025
Latest News
Three-year VenoValve first-in-human trial data published
Envveno Medical has today announced that its manuscript titled, ‘Three-year outcomes of surgical implantation of a novel bioprosthetic valve for the treatment of deep...
Features
No longer a ‘one-trick shop’: Venous becomes core pillar of CX...
Charting the development of the Charing Cross (CX) venous and lymphatic programme from a sidebar event to becoming an “integral part” of the meeting’s...
Thrombectomy gold rush set to follow ATTRACT study, experts argue
At the recent Endo Vascular Access (EVA) meeting (14–15 June, Patras, Greece), Ziv Haskal (University of Virginia School of Medicine, Charlottesville, USA) spoke to...
Videos
Before the STEVECO trial, there were no randomized controlled trial data in the chronic disease space; in its wake, has come a more robust landscape to establish an evidence base: During the 2024 Charing Cross (CX) International Symposium (April...
